CDH1 and breast carcinoma: The EMT profile of each breast cancer cell line under study was evaluated by measuring the protein levels of the epithelial marker E-cadherin and of the mesenchymal markers fibronectin, vimentin and αSMA by Western Blot analysis (Fig. 2a).